Radiomics: Current Applications and Future Directions
MedComm · 2026-06 · 7 (6)
DOI: 10.1002/mco2.70773 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 23.05.2026. Verfasst von Jiangbo Shao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ultrasound Diagnostic Center The First Hospital of Jilin University Jilin China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Radiomics enables high‐throughput extraction of quantitative imaging features to decode tumor phenotypes and biological behaviors, representing a transformative noninvasive tool for precision oncology. In recent years, radiomics has rapidly evolved from static feature analysis to dynamic multi‐dimensional assessment, and it has been widely explored in various solid tumors, yet its pan‐cancer generalization, biological interpretability, and clinical translation still face prominent bottlenecks. Cancer remains the leading cause of global mortality, and solid tumors account for more than 90% of adult malignant cases, while conventional medical imaging and invasive biopsies have inherent limitations in reflecting tumor heterogeneity and dynamic evolution. This review outlines the unified technical pipeline of radiomics across solid tumors, highlights cancer‐specific imaging considerations, and summarizes standardization strategies for multi‐center, multi‐scanner, and multi‐cancer heterogeneity. We systematically review pan‐cancer clinical applications covering early detection, molecular characterization, treatment response prediction, and prognostic stratification, with lung cancer as a paradigmatic example while integrating evidence from breast, colorectal, liver, glioma, and prostate cancers. We also discuss multi‐omics integration, biological interpretability, and translational bottlenecks including domain shift and reproducibility crisis. Finally, we prospect cutting‐edge directions including foundation models, causal inference, and federated learning to advance generalizable and clinically actionable radiomics toward routine clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ultrasound Diagnostic Center The First Hospital of Jilin University Jilin China.
- Department of General Gynecology II, Obstetrics and Gynecology Center The First Hospital of Jilin University Jilin China.
- Department of Emergency Medicine The First Hospital of Jilin University Jilin China.
- Department of Thoracic Surgery II, Department of Lung Transplantation, Organ Transplantation Center The First Hospital of Jilin University Jilin China.
- Department of Hand and Foot Surgery Orthopedics Center The First Hospital of Jilin University Jilin China.
- Cancer Center The First Hospital of Jilin University Jilin China.
ORCID-Profile: Ye Guo
Zitieren
APA
Shao, J., Wei, M., Li, K., Lv, G., Liu, K., & Guo, Y. (2026). Radiomics: Current Applications and Future Directions. MedComm, 7(6). https://doi.org/10.1002/mco2.70773
Vancouver
Shao J, Wei M, Li K, Lv G, Liu K, Guo Y. Radiomics: Current Applications and Future Directions. MedComm. 2026;7(6). doi:10.1002/mco2.70773
BibTeX
@article{Shao2026,
author = {Shao, Jiangbo and Wei, Meng and Li, Ke and Lv, Guangchao and Liu, Kai and Guo, Ye},
title = {Radiomics: Current Applications and Future Directions},
journal = {MedComm},
year = {2026},
volume = {7},
number = {6},
doi = {10.1002/mco2.70773}
}
EUVIMED